Regeneron: Driven by Science

For over 25 years, Regeneron's vision has been to build an innovative company that consistently brings new medicines to patients with serious diseases.

Recent News

Regeneron Reports Second Quarter 2015 Financial and Operating Results

08/04/15

TARRYTOWN, N.Y., Aug. 4, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial results for the second quarter of 2015 and provided an update on development programs. Financial Highlights ($ in m...

Read more

Upcoming Events

Regeneron Pharmaceuticals Q2 2015 Earnings Conference Call

08/04/15 at 8:30 AM ET

View Event




Close
Form content here please :)